These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2601845)

  • 1. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist.
    Cameron DL; Crocker AD
    Neuroscience; 1989; 32(3):769-78. PubMed ID: 2601845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
    Double KL; Crocker AD
    Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL; Crocker AD
    Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens.
    Bordi F; Carr KD; Meller E
    Brain Res; 1989 Jun; 489(2):205-15. PubMed ID: 2568153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL; O'Dell LE; Redmond JC
    Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ; Marshall JF
    Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors.
    Lee CY; Double KL; Crocker AD
    Brain Res; 1995 May; 681(1-2):205-8. PubMed ID: 7552282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
    Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone.
    Double KL; Crocker AD
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1669-73. PubMed ID: 7878037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain.
    Kopp J; Lindefors N; Brené S; Hall H; Persson H; Sedvall G
    Neuroscience; 1992; 47(4):771-9. PubMed ID: 1533704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical modifications induced by apomorphine treatment.
    Piervincenzo P; Luciana G; Laura C; Giuseppe A
    Neurosci Lett; 1989 May; 100(1-3):265-70. PubMed ID: 2761776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine.
    Yokoo H; Goldstein M; Meller E
    Eur J Pharmacol; 1988 Oct; 155(3):323-7. PubMed ID: 3234490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.